CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Delisting notice
- S-1 Offering Registration Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Exit or restructuring costs · Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- NT 10-Q Other NT 10-Q
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 10-Q/A Report 10-Q/A
- 10-K/A Report 10-K/A
Page 6 of 61 · 1,218 filings